Increased operating expenses largely contributed to the drop. Total revenue was up 13 percent over 2012, but operating expenses increased 17 percent, from $90.5 million in 2012 to $106.2 million this past quarter, which ended March 31.
More Articles on Devices:
35 Orthopedic & Spine Devices Receive FDA 510(k) Clearance
Medical Device Tax Costs Will Be Absorbed by Companies, Not Passed to Hospitals
Orthofix’s Slumped Spine, Orthopedic Sales Brought 17% Gross Profit Drop in Q1
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
